期刊文献+

不同体重类型代谢综合征患者冠脉病变程度的比较

The difference of coronary artery stenosis level between over weight or obesity patients and normal weight patients with metabolic syndrome
原文传递
导出
摘要 目的了解不同体重类型代谢综合征患者冠状动脉病变程度的差异。方法选取因胸痛入院行冠脉造影检查并诊断为代谢综合征的患者240例,根据体重指数分为超重或肥胖组(BMI≥25kg/m^2)与正常体重组(BMI〈25kg/m^2)。比较两组患者冠脉病变程度和临床指标的差异。结果超重或肥胖组患者冠脉多支病变发生率高于正常体重组(P〈0.05),冠脉正常发生率低于正常体重组(P〈0.05),两组患者冠脉单支、双支病变发生率无明显差异。发生冠脉多支病变的超重或肥胖组患者的低密度脂蛋白.胆固醇水平高于正常体重组(P〈0.05)。结论冠脉综合征合并肥胖患者更易于发生冠脉多支病变,对于冠脉综合征患者应积极控制体重。 Objective To approach the difference about coronary artery stenosis level between over weight or obesity patients and normal weight patients with metabolic syndrome. Method According to the BMI, 240 patients were divided into the group with over weight or obesity MS( BMI ≥25 kg/m^2) and the group with normal weight MS( BMI 〈 25 kg/m^2). These patients were admitted for chest pain and had been undergone coronary angiography. The two groups were compared for the coronary artery stenosis level. Result The incidence about coronary multi-vessal disease of over weight or obesity MS group was higher than normal weight MS group. The incidence about normal coronary artery of normal weight MS group was higher than over weight or obesity MS group. There were no difference about the incidence of single and double coronary vessal disease between the two groups. The low density lipoprotein level of over weight or obesity MS group with coronary muhi-vessal disease was higher than the normal weight MS group. Conclusion Over weight or obesity MS patients had higher incidence about coronary muhi-vessal disease than normal weight MS patients. The low density lipoprotein level should be controled lower in MS patients.
出处 《临床内科杂志》 CAS 2010年第9期624-626,共3页 Journal of Clinical Internal Medicine
关键词 肥胖 代谢综合征 冠脉病变 Obesity Metabolic syndrome Coronary artery steno
  • 相关文献

参考文献4

  • 1Sattar N,Gaw A,Scherbakova O,et al.Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Comnary Prevention Study.Circulation,2003,108:414-419.
  • 2Jacobson TA,Case CC,Roberts S,et al.Characteristics of US adults with the metabolic syndrome and therapeutic implications.Diabetes Obesity & Metabolism,2004,6:353-362.
  • 3The Scandinavian Simvastatin Survival Study Group.Pandomised trial of lowering in 4444 patients coronary heart disease:the Scandinavian Simvastatin Survival Study(4S).Lancet.1994,344:1383-1389.
  • 4Downs JR,Clearfield M,Weis S,et al.Prinary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCA PS/Tex CAPS Air Force/Texas Coronary Atherosclerosis Prevention Study.JAMA,1998,279:1615-1622.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部